• 1
    Feldman AR, Kersler L., Myers MH, Naughton MD. The prevalence of cancer: estimates based on the Connecticut Tumour Registry. N Engl J Med 1986; 315:13947.
  • 2
    Bonett A., Roder D., Milliken L. The South Australian Cancer Registry: A means of assessing cancer incidence, mortality and case survival. Eur J Cancer 1992; 28A(11):19236.
  • 3
    McWhirter WR, Dobson C., Ring I. Childhood cancer incidence in Australia, 1982–1991. Int J Cancer 1996; 65(1):348.
  • 4
    Australian Institute of Health and Welfare. Cancer in Australia 1991–94 (with projections to 1999). Canberra : AIHW, 1998.
  • 5
    Coory M., Armstrong B. Cancer Incidence Projections for Area and Rural Health Services in New South Wales. Sydney : NSW Cancer Council, 1998.
  • 6
    Threlfall T. Cancer Incidence and Mortality Projections for WA, 1996–2001. Perth : Health Information Centre, Health Department of Western Australia, 1997.
  • 7
    Adami HO, Gunnarson T., Sparen P., Ekind G. The prevalence of cancer in Sweden 1984. Acta Oncol 1989; 28(4):46370.
  • 8
    Engeland A., Haldorsen T., Tretli S., Hakulinen T., Horte L., Luostarinen T., et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis. A collaborative study of the five Nordic cancer registries. APMIS Suppl 1995; 103(49): 1163.
  • 9
    Krogh V., Micheli A. Measure of cancer prevalence with a computerized program: An example on larynx cancer. Tumori 1996; 82:28790.
  • 10
    Polednak AP. Estimating the prevalence of cancer in the United States. Cancer 1997; 80(1):13641.
  • 11
    Tulinius H., Storm H., Pukkala A., Anderson A., Ericson J. Cancer in the nordic countries, 1981–85. APMIS Suppl 1992; 31.
  • 12
    Holman CDJ, Rouse IL, Bass AJ, Hobbs MST. Population-based linkage of health records in Western Australia: Development of the Health Services Research Linked Database. Aust N Z J Public Health 1999; 23(5):4539.
  • 13
    World Health rganization. ICD-O: International Classification of Diseases for Oncology. 2nd ed. Geneva : WHO, 1990.
  • 14
    Capocaccia R., De Angelis RD. Estimating the completeness of prevalence based on cancer registry data. Stat Med 1997; 16:42540.
  • 15
    Coldman AJ, McBride ML, Braun T. Calculating the prevalence of cancer. Stat Med 1992; 11:157989.
  • 16
    Therneau T., Sicks J., Bergstralh E., Offord J. Expected Survival Based on Hazard Rates. Rochester : Mayo Clinic, 1994.
  • 17
    Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 1982; 38:933.
  • 18
    Hakulinen T., Abeywickrama KH. A computer program package for relative survival analysis. Comput Programs Biomed 1985; 19:197207.
  • 19
    Stenbeck M., Rosen M., Sparen P. Causes of increasing cancer prevalence in Sweden. Lancet 1999; 354(9184):10934.
  • 20
    Oncology Education Committee. Ideal Oncology Curriculum for Medical Schools. Sydney : Australian Cancer Society, 1999.
  • 21
    Mathers C., Penm R., Carter R., Stevenson C. Health System Costs of Diseases and Injury in Australia, 1993–94. Canberra : Australian Institute of Health and Welfare, 1998.
  • 22
    Australian Institute of Health and Welfare. Australia's Health Services Expenditure to 1998–99. Canberra : AIHW, 2000. Health Expenditure Bulletin No.: 16:.